Clinical Trial

Feasibility and Tolerability Study of Smart Contact Lens With Healthy Subjects and Patients With Stargardt's Disease

Study acronym: RE-SEE
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Oculometry is becoming increasingly popular in fields such as enhanced reality and healthcare, but remains limited by complex devices that are poorly adapted to the needs of users, particularly the visually impaired. This research proposes to explore a smart contact lens (SCL)-based system to overcome these limitations, particularly for people with central visual deficits such as Stargardt's disease.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-23.
Trial Details
NCT Number NCT06989658
Lead Sponsor Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Collaborators: Ecole Nationale Supérieure Mines - Télécom Atlantique Bretagne Pays de la Loire., StreetLab Vision
Conditions Stargardt Disease
Enrollment 32 participants
Start Date 2025-10
Primary Completion 2028-02 (estimated)
Study Completion 2028-02 (estimated)
Updated on ClinicalTrials.gov 2025-09-18